2011年AASLD基因1型丙型肝炎诊疗指南要点简介

摘要

2011 practice guideline on the treatment of genotype 1 chronic hepatitis C virus infection by the American Association ior the Study of Liver Diseases was published in Hepatology in Oct. 2011. As boceprevir and lelaprevir were approved in the United Stales and subsequently in Furope, the guideline was come out with time characleristics. The article focuses on the introduction of the key points of the guideline.%2011年10月Hepatology全文刊发了美国肝病研究学会的2011年版基因1型慢性丙型肝炎的诊疗指南.该指南是基于boceprevir和telaprevir在美国和欧洲相继上市而发布的,具有显著的时间特色.本文对该指南的有关要点进行介绍.